ASX:Live
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Valuation
Value
Consensus
Momentum
Price
Neutral
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
N/A
Telephone
61.3.9046.9700
Address
Level 8 31 Queen Street Melbourne, Victoria (VIC) 3000
Description
Knosys Ltd. engages in the provision of computer software development and licensing services. The firm also offers enterprise content management, process guidance, workflow, enterprise data virtualization, and user self-service. The company was founded on March 16, 2015 and is headquartered in Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.03 - 0.05
Trade Value (12mth)
AU$1,715.00
1 week
-2.63%
1 month
-7.5%
YTD
-11.9%
1 year
5.71%
All time high
0.41
EPS 3 yr Growth
-128.10%
EBITDA Margin
0.80%
Operating Cashflow
$2m
Free Cash Flow Return
31.60%
ROIC
2.70%
Interest Coverage
16.80
Quick Ratio
1.00
Shares on Issue (Fully Dilluted)
216m
HALO Sector
Technology
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
| Date | Announcements |
|---|---|
|
27 February 25 |
Half Year results release
×
Half Year results release |
|
27 February 25 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
|
30 January 25 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
|
17 December 24 |
Investor Newsletter - December 2024
×
Investor Newsletter - December 2024 |
|
12 December 24 |
Optus signs contract extension
×
Optus signs contract extension |
|
28 November 24 |
Results of Meeting
×
Results of Meeting |
|
28 November 24 |
AGM - MD Presentation
×
AGM - MD Presentation |
|
21 November 24 |
Knosys signs 2-year contract extension with Healthdirect
×
Knosys signs 2-year contract extension with Healthdirect |
|
31 October 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
|
15 October 24 |
AGM Letter to Shareholders
×
AGM Letter to Shareholders |
|
15 October 24 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
|
19 September 24 |
Singtel contract extension
×
Singtel contract extension |
|
10 September 24 |
Date of 2024 AGM
×
Date of 2024 AGM |
|
03 September 24 |
Knosys wins new Knowledge IQ 5-year contract with OPP WA
×
Knosys wins new Knowledge IQ 5-year contract with OPP WA |
|
30 August 24 |
Knosys Financial Results release June 2024
×
Knosys Financial Results release June 2024 |
|
30 August 24 |
Appendix 4G
×
Appendix 4G |
|
30 August 24 |
Annual Report to shareholders
×
Annual Report to shareholders |
|
30 August 24 |
Appendix 4E
×
Appendix 4E |
|
26 July 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
|
24 July 24 |
Notification of cessation of securities - KNO
×
Notification of cessation of securities - KNO |
|
23 July 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
|
30 May 24 |
Knosys Webinar presentation slides - Webinar at 11am
×
Knosys Webinar presentation slides - Webinar at 11am |
|
16 May 24 |
Notice of Growth Strategy Webinar - 30 May 2024 at 11am
×
Notice of Growth Strategy Webinar - 30 May 2024 at 11am |
|
30 April 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
|
27 February 24 |
December 2023 Half year results release
×
December 2023 Half year results release |
Load More
Load Less
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
.svg)
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.
